Text Size
70 studies found for:    weill | "RNA Virus Infections"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Unknown † Intrahepatic HCV RNA and Telaprevir Kinetics in Hepatitis C Virus (HCV)
Condition: Hepatitis C
Intervention: Drug: Telaprevir
2 Terminated Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin
Conditions: Anemia;   Neutropenia;   Hepatitis C Virus;   HIV Infections
Intervention: Drug: erythropoietin, GCSF
3 Terminated Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype I
Condition: Hepatitis C
Interventions: Biological: Interleukin 2;   Drug: Ribavirin;   Biological: Pegylated Interferon Alpha;   Biological: Inteleukin-2;   Drug: Ribavirin + Pegylated interferon-alpha
4 Unknown † The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Hepatitis C;   Liver Cirrhosis
Intervention: Drug: Rifaximin (drug)
5 Completed Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
Conditions: HIV-Associated Lipodystrophy Syndrome;   Insulin Resistance;   HIV Infections;   Metabolic Syndrome X;   Body Weight Changes
Interventions: Drug: Rosiglitazone;   Drug: Recombinant human growth hormone + rosiglitazone
6 Recruiting Armodafinil for Patients Starting Hepatitis C Virus Treatment
Condition: Hepatitis C
Interventions: Drug: Armodafinil;   Drug: Placebo
7 Enrolling by invitation Hepatitis C Treatment in Underserved Populations
Conditions: Chronic Hepatitis C;   Illicit Drug Use
Intervention: Other: Collaborative, multidisciplinary, integrated care
8 Completed The Shang Ring: A Novel Male Circumcision Device for HIV Prevention
Conditions: Male Circumcision;   HIV Prevention;   HIV Infections
Intervention: Device: Shang Ring circumcision
9 Completed Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve Subjects
Condition: Chronic Hepatitis C
Intervention: Drug: Ribavirin, PEG-Intron
10 Completed Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Nitazoxanide;   Drug: Placebo;   Biological: Peginterferon alfa-2a;   Drug: Ribavirin
11 Completed Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV
Condition: HIV Infections
Interventions: Biological: ALVAC HIV vaccine (vCP1452);   Drug: Interleukin-2
12 Completed
Has Results 		HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV
Condition: HIV Infections
Interventions: Drug: Efavirenz;   Drug: Emtricitabine/Tenofovir disoproxil fumarate
13 Completed Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients
Condition: Chronic Hepatitis C
Interventions: Drug: Nitazoxanide;   Drug: Placebo;   Biological: Peginterferon alfa-2a;   Drug: Ribavirin
14 Not yet recruiting Enhanced Access to HIV Care for Drug Users in San Juan, Puerto Rico
Conditions: HIV;   AIDS;   Substance Abuse
Interventions: Behavioral: Enhanced HIV Care Access and Retention Intervention;   Behavioral: HIV Testing Campaign;   Behavioral: Treatment Re-engagement Campaign;   Behavioral: Patient Navigator Linkage to Care and Substance Abuse Treatment Team;   Behavioral: Mobile Care Clinic
15 Completed A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Nevirapine;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Didanosine
16 Terminated Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus
Conditions: Chronic Hepatitis;   Hepatitis B
Interventions: Drug: Clevudine;   Drug: Adefovir
17 Recruiting Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)
Condition: Hepatitis C Virus
Interventions: Drug: Asunaprevir (ASV);   Drug: Daclatasvir (DCV);   Drug: PBO matching ASV;   Drug: Placebo (PBO) matching DCV;   Drug: Pegylated-interferon alfa 2a (PegIFN);   Drug: Ribavirin (RBV)
18 Recruiting HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
Condition: Hepatitis C
Intervention:
19 Active, not recruiting Study Comparing BMS-790052 (Daclatasvir) to Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Untreated Hepatitis C Patients
Condition: Hepatitis C
Interventions: Drug: BMS-790052 (Daclatasvir);   Drug: Telaprevir;   Drug: Peginterferon alfa-2a;   Drug: Ribavirin
20 Recruiting Open-Label Study of GS-7977+ Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies
Condition: Chronic Hepatitis C
Interventions: Drug: GS-7977 in combination with ribavirin;   Drug: GS-7977 400mg QD+ RBV BID+ PEG
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years